To include your compound in the COVID-19 Resource Center, submit it here.

CLX-0901: Began Phase II trial

Calyx Therapeutics Inc., Hayward, Calif.

Read the full 55 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE